CCR5 and HIV infectious disease: To determine the impact of cell-associated GAGs on the enhancement of HIV infection by defensins, HeLa-CD4-CCR5 cells were treated with heparinase I, which removes heparin and heparan sulfate and blocks HIV attachment [33].